Official Title
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Brief Summary

CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage of a blood sample for storage . The study will be conducted in up to 30 sites within Australia.

Active, not recruiting
HIV-1-infection
Cancer
Primary Immune Deficiency Disorder
Immunosuppression Disorders
COVID-19
Eligibility Criteria

Inclusion Criteria:

1. Presenting (in person or via telemedicine) for evaluation because they:

- Have clinical symptoms consistent with for COVID-19:

- Fever (≥ 37.8 °C) on examination OR patient reported fever (≥ 37.8 °C) or
feverishness (felt febrile but did not take temperature) OR any of, cough, sore
throat, shortness of breath, rhinorrhoea, headache, chills, generalise myalgia,
malaise, fatigue, confusion, diarrhea, nausea or vomiting

- Have been contacted because they have been identified as a contact to a confirmed
case

- Have been contacted and told they tested positive for COVID-19

2. Have one of the following conditions affecting immune function:

- Known or suspected primary immunodeficiency, defined as a predisposition to
infection associated with an apparent or presumed deficit of immune function

- On immunosuppressive therapy

- Treatment with immune checkpoint inhibitors within 36 months of enrolment date

- HIV infection

- Diagnosis of cancer within 36 months of enrolment date, excluding superficial
basal cell and squamous cell carcinomas

- Solid organ transplantation

3. For optional biobanking only, ability to provide informed consent

Exclusion Criteria:

- Nil

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Australia
Locations

St Vincent's Hospital
Darlinghurst, New South Wales, Australia

East Sydney Doctors
Sydney, New South Wales, Australia

Royal North Shore Hospital
Sydney, New South Wales, Australia

Blacktown Hospital
Sydney, New South Wales, Australia

Liverpool Hospital
Sydney, New South Wales, Australia

St George Hospital
Sydney, New South Wales, Australia

Concord Hospital
Sydney, New South Wales, Australia

Holdsworth House Medical Practice
Sydney, New South Wales, Australia

Melanoma Institute Australia
Sydney, New South Wales, Australia

Nepean Hospital
Sydney, New South Wales, Australia

Westmead Hospital
Sydney, New South Wales, Australia

Mark Polizzotto, MD, Principal Investigator
Kirby Institute, UNSW

Kirby Institute
NCT Number
MeSH Terms
COVID-19
Primary Immunodeficiency Diseases
Immunologic Deficiency Syndromes